Mediclinic International PLC | Income Statement
Fiscal year is April-March. All values GBP Millions.
2013
2014
2016
2017
2018
2019
Sales/Revenue
234
273
2,107
2,749
2,870
2,932
Cost of Goods Sold (COGS) incl. D&A
136
158
1,281
1,734
1,829
1,871
Gross Income
98
115
826
1,015
1,041
1,061
SG&A Expense
50
63
538
651
687
736
Unusual Expense
-
4
7
14
749
407
Non Operating Income/Expense
1
-
1
3
7
1
Interest Expense
4
1
66
87
98
66
Pretax Income
39
51
239
295
482
140
Equity in Affiliates
-
-
6
12
3
3
Consolidated Net Income
39
51
190
243
474
130
Net Income
39
49
177
229
492
151
Net Income After Extraordinaries
39
49
177
229
492
151
Net Income Available to Common
39
49
177
229
492
151
EPS (Basic)
0.36
0.42
0.30
0.31
0.67
0.20
Basic Shares Outstanding
109
117
598
737
737
737
EPS (Diluted)
0.36
0.42
0.30
0.31
0.67
0.20
Diluted Shares Outstanding
109
117
599
737
737
737
EBITDA
53
60
381
509
531
493
Other Operating Expense
-
-
-
-
9
-
Non-Operating Interest Income
-
1
9
7
9
9
Minority Interest Expense
-
2
13
14
18
21
About Mediclinic International
View Profile
